• Pharnext webcast 20 may 2020

    Find the overview of Pharnext’s ongoing business strategy provided by David Horn Solomon, CEO of Pharnext, on May 20, 2020



  • R&D Day 13 october 2020

    Pharnext to hold a Virtual R&D Day Event to discuss unmet need in Charcot-Marie-Tooth Disease Type 1A and potential for PXT3003 as a disease modifying treatment on October 13, 2020.
    Read more


  • JP MORGAN 2021 11-14 January 2021

    Pharnext will attend the J.P. Morgan 39th Annual Healthcare Conference on January 11-14, 2021 in San Francisco, US

    Read more